WO2022197752A1 - Sélection d'ensembles de poids basée sur l'emplacement d'un élément et/ou le cycle pour appel de base - Google Patents
Sélection d'ensembles de poids basée sur l'emplacement d'un élément et/ou le cycle pour appel de base Download PDFInfo
- Publication number
- WO2022197752A1 WO2022197752A1 PCT/US2022/020460 US2022020460W WO2022197752A1 WO 2022197752 A1 WO2022197752 A1 WO 2022197752A1 US 2022020460 W US2022020460 W US 2022020460W WO 2022197752 A1 WO2022197752 A1 WO 2022197752A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weights
- sensing cycles
- weight set
- subseries
- data
- Prior art date
Links
- 230000002123 temporal effect Effects 0.000 claims abstract description 123
- 238000013528 artificial neural network Methods 0.000 claims abstract description 120
- 238000012163 sequencing technique Methods 0.000 claims abstract description 117
- 238000012545 processing Methods 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 60
- 230000015654 memory Effects 0.000 claims abstract description 58
- 230000008569 process Effects 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims description 121
- 238000012549 training Methods 0.000 claims description 24
- 238000003556 assay Methods 0.000 claims description 9
- 238000011068 loading method Methods 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 142
- 230000002093 peripheral effect Effects 0.000 description 56
- 238000003062 neural network model Methods 0.000 description 51
- 125000003729 nucleotide group Chemical group 0.000 description 42
- 239000002773 nucleotide Substances 0.000 description 40
- 239000012530 fluid Substances 0.000 description 36
- 230000006870 function Effects 0.000 description 34
- 238000003860 storage Methods 0.000 description 31
- 150000007523 nucleic acids Chemical class 0.000 description 28
- 108020004707 nucleic acids Proteins 0.000 description 26
- 102000039446 nucleic acids Human genes 0.000 description 26
- 239000000126 substance Substances 0.000 description 26
- 230000005284 excitation Effects 0.000 description 25
- 238000005070 sampling Methods 0.000 description 23
- 238000005286 illumination Methods 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 20
- 238000003491 array Methods 0.000 description 19
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 238000010586 diagram Methods 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- 238000004891 communication Methods 0.000 description 16
- 238000001514 detection method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 230000009471 action Effects 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 238000004166 bioassay Methods 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000002161 passivation Methods 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 8
- 230000002441 reversible effect Effects 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000005562 fading Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000376 reactant Substances 0.000 description 7
- 238000012384 transportation and delivery Methods 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 230000001133 acceleration Effects 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 238000013135 deep learning Methods 0.000 description 6
- 238000010606 normalization Methods 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000001444 catalytic combustion detection Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 238000013527 convolutional neural network Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 108091028732 Concatemer Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 238000012952 Resampling Methods 0.000 description 2
- 229910052581 Si3N4 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000013144 data compression Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 238000013090 high-throughput technology Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- -1 other biomolecules Substances 0.000 description 2
- 238000013139 quantization Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- PHIYHIOQVWTXII-UHFFFAOYSA-N 3-amino-1-phenylpropan-1-ol Chemical compound NCCC(O)C1=CC=CC=C1 PHIYHIOQVWTXII-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 240000001436 Antirrhinum majus Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000002165 resonance energy transfer Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/045—Combinations of networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/06—Physical realisation, i.e. hardware implementation of neural networks, neurons or parts of neurons
- G06N3/063—Physical realisation, i.e. hardware implementation of neural networks, neurons or parts of neurons using electronic means
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/04—Architecture, e.g. interconnection topology
- G06N3/048—Activation functions
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- General Health & Medical Sciences (AREA)
- Software Systems (AREA)
- Biomedical Technology (AREA)
- Evolutionary Computation (AREA)
- Medical Informatics (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mathematical Physics (AREA)
- General Engineering & Computer Science (AREA)
- Computing Systems (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Computational Linguistics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
Abstract
Système d'appel de bases comprenant une mémoire stockant une topologie d'un réseau neuronal, une pluralité d'ensembles de poids, et des données de capteur pour une série de cycles de détection. Des événements de séquençage s'étendent sur une courbe temporelle de l'opération d'appel de base tout au long d'une sous-série de cycles de détection, et sur une courbe spatiale de l'opération d'appel de base à travers des emplacements sur un biocapteur. Un processeur configurable est configuré pour charger la topologie sur le processeur configurable, sélectionner un ensemble de poids en fonction d'une sous-série donnée de cycles de détection et/ou d'un emplacement donné sur le biocapteur, charger des données de capteur donné pour la sous-série donnée de cycles de détection et l'emplacement donné sur les éléments de traitement, configurer la topologie à l'aide de l'ensemble de poids sélectionné, et amener le réseau neuronal à traiter les données de capteur donné pour produire des données de classification d'appel de base pour la sous-série donnée et l'emplacement donné.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020227045560A KR20230157230A (ko) | 2021-03-16 | 2022-03-15 | 염기 호출을 위한 타일 위치 및/또는 사이클 기반 가중치 세트 선택 |
| AU2022238841A AU2022238841A1 (en) | 2021-03-16 | 2022-03-15 | Tile location and/or cycle based weight set selection for base calling |
| CN202280005111.4A CN115803815A (zh) | 2021-03-16 | 2022-03-15 | 用于碱基检出的基于区块位置和/或循环的权重集选择 |
| EP22714689.1A EP4309179A1 (fr) | 2021-03-16 | 2022-03-15 | Sélection d'ensembles de poids basée sur l'emplacement d'un élément et/ou le cycle pour appel de base |
| IL299077A IL299077A (en) | 2021-03-16 | 2022-03-15 | Placing tiles and/or choosing a cycle-based weight set for naming the bases |
| CA3183581A CA3183581A1 (fr) | 2021-03-16 | 2022-03-15 | Selection d'ensembles de poids basee sur l'emplacement d'un element et/ou le cycle pour appel de base |
| JP2022580969A JP2024510539A (ja) | 2021-03-16 | 2022-03-15 | ベースコールのためのタイル位置及び／又はサイクルベースの重みセット選択 |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161896P | 2021-03-16 | 2021-03-16 | |
| US202163161880P | 2021-03-16 | 2021-03-16 | |
| US63/161,896 | 2021-03-16 | ||
| US63/161,880 | 2021-03-16 | ||
| US17/687,583 | 2022-03-04 | ||
| US17/687,551 | 2022-03-04 | ||
| US17/687,551 US20220301657A1 (en) | 2021-03-16 | 2022-03-04 | Tile location and/or cycle based weight set selection for base calling |
| US17/687,583 US20220300811A1 (en) | 2021-03-16 | 2022-03-04 | Neural network parameter quantization for base calling |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022197752A1 true WO2022197752A1 (fr) | 2022-09-22 |
Family
ID=81325254
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2022/020460 WO2022197752A1 (fr) | 2021-03-16 | 2022-03-15 | Sélection d'ensembles de poids basée sur l'emplacement d'un élément et/ou le cycle pour appel de base |
| PCT/US2022/020462 WO2022197754A1 (fr) | 2021-03-16 | 2022-03-15 | Quantification de paramètres de réseau neuronal pour appel de base |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2022/020462 WO2022197754A1 (fr) | 2021-03-16 | 2022-03-15 | Quantification de paramètres de réseau neuronal pour appel de base |
Country Status (1)
| Country | Link |
|---|---|
| WO (2) | WO2022197752A1 (fr) |
Citations (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991006678A1 (fr) | 1989-10-26 | 1991-05-16 | Sri International | Sequençage d'adn |
| US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
| US6090592A (en) | 1994-08-03 | 2000-07-18 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid on supports |
| US20020055100A1 (en) | 1997-04-01 | 2002-05-09 | Kawashima Eric H. | Method of nucleic acid sequencing |
| US20040002090A1 (en) | 2002-03-05 | 2004-01-01 | Pascal Mayer | Methods for detecting genome-wide sequence variations associated with a phenotype |
| WO2004018497A2 (fr) | 2002-08-23 | 2004-03-04 | Solexa Limited | Nucleotides modifies |
| US20040096853A1 (en) | 2000-12-08 | 2004-05-20 | Pascal Mayer | Isothermal amplification of nucleic acids on a solid support |
| WO2005065814A1 (fr) | 2004-01-07 | 2005-07-21 | Solexa Limited | Arrangements moleculaires modifies |
| US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| WO2006064199A1 (fr) | 2004-12-13 | 2006-06-22 | Solexa Limited | Procede ameliore de detection de nucleotides |
| US7115400B1 (en) | 1998-09-30 | 2006-10-03 | Solexa Ltd. | Methods of nucleic acid amplification and sequencing |
| US20060240439A1 (en) | 2003-09-11 | 2006-10-26 | Smith Geoffrey P | Modified polymerases for improved incorporation of nucleotide analogues |
| US20060281471A1 (en) | 2005-06-08 | 2006-12-14 | Cisco Technology,Inc. | Method and system for communicating using position information |
| WO2007010251A2 (fr) | 2005-07-20 | 2007-01-25 | Solexa Limited | Preparation de matrices pour sequencage d'acides nucleiques |
| US7211414B2 (en) | 2000-12-01 | 2007-05-01 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| US20070128624A1 (en) | 2005-11-01 | 2007-06-07 | Gormley Niall A | Method of preparing libraries of template polynucleotides |
| WO2007123744A2 (fr) | 2006-03-31 | 2007-11-01 | Solexa, Inc. | Systèmes et procédés pour analyse de séquençage par synthèse |
| US7315019B2 (en) | 2004-09-17 | 2008-01-01 | Pacific Biosciences Of California, Inc. | Arrays of optical confinements and uses thereof |
| US20080009420A1 (en) | 2006-03-17 | 2008-01-10 | Schroth Gary P | Isothermal methods for creating clonal single molecule arrays |
| US7329492B2 (en) | 2000-07-07 | 2008-02-12 | Visigen Biotechnologies, Inc. | Methods for real-time single molecule sequence determination |
| US7405281B2 (en) | 2005-09-29 | 2008-07-29 | Pacific Biosciences Of California, Inc. | Fluorescent nucleotide analogs and uses therefor |
| US20080234136A1 (en) | 2005-06-15 | 2008-09-25 | Complete Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
| US20080242560A1 (en) | 2006-11-21 | 2008-10-02 | Gunderson Kevin L | Methods for generating amplified nucleic acid arrays |
| US7592435B2 (en) | 2005-08-19 | 2009-09-22 | Illumina Cambridge Limited | Modified nucleosides and nucleotides and uses thereof |
| US7595882B1 (en) | 2008-04-14 | 2009-09-29 | Geneal Electric Company | Hollow-core waveguide-based raman systems and methods |
| US20130079232A1 (en) | 2011-09-23 | 2013-03-28 | Illumina, Inc. | Methods and compositions for nucleic acid sequencing |
| US10152776B2 (en) * | 2017-03-07 | 2018-12-11 | Illumina, Inc. | Optical distortion correction for imaged samples |
| US20200302224A1 (en) * | 2019-03-21 | 2020-09-24 | Illumina, Inc. | Artificial Intelligence-Based Sequencing |
| CA3104851A1 (fr) * | 2019-05-16 | 2020-11-19 | Illumina, Inc. | Appel de base au moyen de convolutions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10491239B1 (en) * | 2017-02-02 | 2019-11-26 | Habana Labs Ltd. | Large-scale computations using an adaptive numerical format |
| KR20200043169A (ko) * | 2018-10-17 | 2020-04-27 | 삼성전자주식회사 | 뉴럴 네트워크의 파라미터를 양자화하는 방법 및 장치 |
-
2022
- 2022-03-15 WO PCT/US2022/020460 patent/WO2022197752A1/fr active Application Filing
- 2022-03-15 WO PCT/US2022/020462 patent/WO2022197754A1/fr active Application Filing
Patent Citations (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991006678A1 (fr) | 1989-10-26 | 1991-05-16 | Sri International | Sequençage d'adn |
| US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
| US6090592A (en) | 1994-08-03 | 2000-07-18 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid on supports |
| US20020055100A1 (en) | 1997-04-01 | 2002-05-09 | Kawashima Eric H. | Method of nucleic acid sequencing |
| US7115400B1 (en) | 1998-09-30 | 2006-10-03 | Solexa Ltd. | Methods of nucleic acid amplification and sequencing |
| US7329492B2 (en) | 2000-07-07 | 2008-02-12 | Visigen Biotechnologies, Inc. | Methods for real-time single molecule sequence determination |
| US7211414B2 (en) | 2000-12-01 | 2007-05-01 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
| US20040096853A1 (en) | 2000-12-08 | 2004-05-20 | Pascal Mayer | Isothermal amplification of nucleic acids on a solid support |
| US20060188901A1 (en) | 2001-12-04 | 2006-08-24 | Solexa Limited | Labelled nucleotides |
| US7566537B2 (en) | 2001-12-04 | 2009-07-28 | Illumina Cambridge Limited | Labelled nucleotides |
| US7427673B2 (en) | 2001-12-04 | 2008-09-23 | Illumina Cambridge Limited | Labelled nucleotides |
| US7057026B2 (en) | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| US20040002090A1 (en) | 2002-03-05 | 2004-01-01 | Pascal Mayer | Methods for detecting genome-wide sequence variations associated with a phenotype |
| WO2004018497A2 (fr) | 2002-08-23 | 2004-03-04 | Solexa Limited | Nucleotides modifies |
| US7541444B2 (en) | 2002-08-23 | 2009-06-02 | Illumina Cambridge Limited | Modified nucleotides |
| US20070166705A1 (en) | 2002-08-23 | 2007-07-19 | John Milton | Modified nucleotides |
| US20060240439A1 (en) | 2003-09-11 | 2006-10-26 | Smith Geoffrey P | Modified polymerases for improved incorporation of nucleotide analogues |
| WO2005065814A1 (fr) | 2004-01-07 | 2005-07-21 | Solexa Limited | Arrangements moleculaires modifies |
| US20110059865A1 (en) | 2004-01-07 | 2011-03-10 | Mark Edward Brennan Smith | Modified Molecular Arrays |
| US7315019B2 (en) | 2004-09-17 | 2008-01-01 | Pacific Biosciences Of California, Inc. | Arrays of optical confinements and uses thereof |
| WO2006064199A1 (fr) | 2004-12-13 | 2006-06-22 | Solexa Limited | Procede ameliore de detection de nucleotides |
| US20060281471A1 (en) | 2005-06-08 | 2006-12-14 | Cisco Technology,Inc. | Method and system for communicating using position information |
| US20080234136A1 (en) | 2005-06-15 | 2008-09-25 | Complete Genomics, Inc. | Single molecule arrays for genetic and chemical analysis |
| WO2007010251A2 (fr) | 2005-07-20 | 2007-01-25 | Solexa Limited | Preparation de matrices pour sequencage d'acides nucleiques |
| US7592435B2 (en) | 2005-08-19 | 2009-09-22 | Illumina Cambridge Limited | Modified nucleosides and nucleotides and uses thereof |
| US7405281B2 (en) | 2005-09-29 | 2008-07-29 | Pacific Biosciences Of California, Inc. | Fluorescent nucleotide analogs and uses therefor |
| US20070128624A1 (en) | 2005-11-01 | 2007-06-07 | Gormley Niall A | Method of preparing libraries of template polynucleotides |
| US20080009420A1 (en) | 2006-03-17 | 2008-01-10 | Schroth Gary P | Isothermal methods for creating clonal single molecule arrays |
| WO2007123744A2 (fr) | 2006-03-31 | 2007-11-01 | Solexa, Inc. | Systèmes et procédés pour analyse de séquençage par synthèse |
| US20080242560A1 (en) | 2006-11-21 | 2008-10-02 | Gunderson Kevin L | Methods for generating amplified nucleic acid arrays |
| US7595882B1 (en) | 2008-04-14 | 2009-09-29 | Geneal Electric Company | Hollow-core waveguide-based raman systems and methods |
| US20130079232A1 (en) | 2011-09-23 | 2013-03-28 | Illumina, Inc. | Methods and compositions for nucleic acid sequencing |
| US10152776B2 (en) * | 2017-03-07 | 2018-12-11 | Illumina, Inc. | Optical distortion correction for imaged samples |
| US20200302224A1 (en) * | 2019-03-21 | 2020-09-24 | Illumina, Inc. | Artificial Intelligence-Based Sequencing |
| CA3104851A1 (fr) * | 2019-05-16 | 2020-11-19 | Illumina, Inc. | Appel de base au moyen de convolutions |
Non-Patent Citations (1)
| Title |
|---|
| BENTLEY ET AL., NATURE, vol. 456, 2008, pages 53 - 59 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022197754A1 (fr) | 2022-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210265018A1 (en) | Knowledge Distillation and Gradient Pruning-Based Compression of Artificial Intelligence-Based Base Caller | |
| US20220301657A1 (en) | Tile location and/or cycle based weight set selection for base calling | |
| AU2020276115A1 (en) | Systems and devices for characterization and performance analysis of pixel-based sequencing | |
| US20210265015A1 (en) | Hardware Execution and Acceleration of Artificial Intelligence-Based Base Caller | |
| US20230041989A1 (en) | Base calling using multiple base caller models | |
| WO2022197752A1 (fr) | Sélection d'ensembles de poids basée sur l'emplacement d'un élément et/ou le cycle pour appel de base | |
| AU2022238841A1 (en) | Tile location and/or cycle based weight set selection for base calling | |
| US20230029970A1 (en) | Quality score calibration of basecalling systems | |
| US20230026084A1 (en) | Self-learned base caller, trained using organism sequences | |
| US20220415445A1 (en) | Self-learned base caller, trained using oligo sequences | |
| WO2023014741A1 (fr) | Assignation de bases utilisant de multiples modèles de systèmes d'assignation de bases | |
| CA3224382A1 (fr) | Organe d'appel de base auto-appris, entraine a l'aide d'oligo-sequences | |
| WO2023009758A1 (fr) | Étalonnage de score de qualité de systèmes d'appel de bases | |
| CN117546248A (zh) | 使用多个碱基检出器模型的碱基检出 | |
| CN117529780A (zh) | 碱基检出系统的质量分数校准 | |
| CN117501372A (zh) | 使用生物体序列训练的自学碱基检出器 | |
| TW202309841A (zh) | 用於即時提取從反應位點發射之照明中串擾的方法及系統 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22714689 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 3183581 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022580969 Country of ref document: JP |
|
| ENP | Entry into the national phase |
Ref document number: 2022238841 Country of ref document: AU Date of ref document: 20220315 Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2022714689 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2022714689 Country of ref document: EP Effective date: 20231016 |